260 related articles for article (PubMed ID: 21252160)
41. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
[TBL] [Abstract][Full Text] [Related]
42. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
43. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
46. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
[TBL] [Abstract][Full Text] [Related]
47. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
[TBL] [Abstract][Full Text] [Related]
48. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
[TBL] [Abstract][Full Text] [Related]
49.
Gao X; Wang X
Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):821-828. PubMed ID: 34284697
[TBL] [Abstract][Full Text] [Related]
50. Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis.
Pan Y; Cao F; Guo A; Chang W; Chen X; Ma W; Gao X; Guo S; Fu C; Zhu J
Br J Cancer; 2015 Sep; 113(5):763-72. PubMed ID: 26196185
[TBL] [Abstract][Full Text] [Related]
51. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
52. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
54. Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer.
Ekanem TI; Tsai WL; Lin YH; Tan WQ; Chang HY; Huang TC; Chen HY; Lee KH
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842685
[TBL] [Abstract][Full Text] [Related]
55. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
56. Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer.
Wang W; Chen Y; Deng J; Zhou J; Gu X; Tang Y; Zhang G; Tan Y; Ge Z; Huang Y; Wang S; Zhou J; Zhou Y; Zhou S
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1603-12. PubMed ID: 25652886
[TBL] [Abstract][Full Text] [Related]
57. The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer.
Theophanous E; Petraki C; Scorilas A; Komborozos V; Veloudis G; Varga JL; Zarandi M; Schally AV; Koutsilieris M
Mol Med; 2009; 15(7-8):242-7. PubMed ID: 19593408
[TBL] [Abstract][Full Text] [Related]
58. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
59. Metastasis-associated protein 3 in colorectal cancer determines tumor recurrence and prognosis.
Huang Y; Li Y; He F; Wang S; Li Y; Ji G; Liu X; Zhao Q; Li J
Oncotarget; 2017 Jun; 8(23):37164-37171. PubMed ID: 28418887
[TBL] [Abstract][Full Text] [Related]
60. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
